Reliq Health Technologies, Inc. Announces New Contracts with Four US Physician Practices, Adding over 2,000 New Patients
Reliq Health Technologies (OTC:RQHTF) has signed contracts with four new US primary care practices to implement its iUGO Care platform for chronic disease management. The CEO, Dr. Lisa Crossley, highlighted the expanding eligibility of Medicare and Medicaid patients for virtual care, leading to increased demand for iUGO Care. Reliq anticipates onboarding over 2,000 patients, generating average revenue of $50 per patient monthly, with completion expected in early 2022. This growth follows a quiet first half of 2021 due to the pandemic.
- Contracts signed with four new US primary care practices.
- Anticipated onboarding of over 2,000 patients.
- Average potential revenue of $50 per patient per month.
- None.
HAMILTON, Ontario, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has signed contracts with four new primary care physician practices in the US to provide its iUGO Care platform to their chronic disease patients.
“We are excited to be adding these four new physician practices and their Medicare and Medicaid patients,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “As both Medicaid and Medicare expand the scope of their virtual care programs to include additional conditions such as high risk pregnancy, solid organ disease, musculoskeletal conditions and others, the eligible patient population for Reliq’s products and services continues to increase. Demand for the iUGO Care platform is steadily increasing as clinicians recognize the significant revenue potential associated with offering virtual care programs to their at-risk patients. As we predicted at the beginning of this year, we are experiencing tremendous growth in the second half of 2021 after a relatively quiet first half of the year due to the pandemic. We expect to onboard over 2,000 patients with these clients at an average revenue of
Reliq Health
Reliq Health Technologies is a rapidly growing global telemedicine company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information please contact:
Company Contact
Investor Relations at ir@reliqhealth.com
US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
FAQ
What recent contracts did Reliq Health Technologies sign?
What is the expected revenue increase for Reliq Health from the new contracts?
When is the onboarding of new patients expected to be completed?
